George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.70 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EFG Hermes Third Quarter 2015 Results

11 Nov 2015 07:52

RNS Number : 3015F
EFG-Hermes Holdings SAE
11 November 2015
 

EFG HERMES REPORTS THIRD QUARTER 2015GROUP EARNINGS OF EGP120 MILLION; ON TOTAL OPERATING REVENUES OF EGP668 MILLION

http://www.rns-pdf.londonstockexchange.com/rns/3015F_-2015-11-11.pdfhttp://www.rns-pdf.londonstockexchange.com/rns/3015F_1-2015-11-11.pdf

Cairo, November 11th, 2015 - EFG Hermes reported today Group net profit after tax and minority interest of EGP120 million in 3Q15, up 19% Y-o-Y. Total assets stood at EGP89 billion at the end of 3Q15.

Key Highlights

3Q2015

· The Group reported a strong set of results, with top line growth filtering into Group net profit after tax and minority interest ("NPAT") of EGP120 million, up 19% Y-o-Y in 3Q15.

· The Group managed to protect its margins albeit turbulent operating environment, maintaining its net operating profit margin above the 40% mark, at 41% in 3Q15.

 

· With a well-managed operating platform functioning in very difficult capital market conditions, the Investment Bank results showed resilience, as the Investment Bank delivered an operating revenue of EGP228 million in 3Q15, marginally down 3% Y-o-Y. This translates into a NPAT of EGP40 million, down 7% Y-o-Y in 3Q15.

 

· Of the fee and commission revenue, Investment Banking division continued to grow its revenues up 22% Y-o-Y to EGP50 million in 3Q15, asserting its leadership position in its home market. Brokerage revenue declined 25% to EGP68 million, as volumes contracted across all operating markets, however it maintained its strong market share and ranking across the Region. Asset Management revenue declined 10% Y-o-Y to EGP45 million in 3Q15 on lower performance fees. Private Equity revenue was broadly flat, slipping 1% to EGP23 million in 3Q15.

 

· The Investment Bank operating expenses changing slightly Y-o-Y, as management diligently manages expenses, maintaining a lean and flexible cost structure in a sustainable fashion. The Investment Bank operating expenses came at EGP155 million, up 4% Y-o-Y in 3Q15, despite upward pressure from headcount expansion of 6% Y-o-Y, local currency (EGP) deprecation, and inflationary pressures.

 

· Credit Libanais posted a net profit after tax of USD18.4 million, up 2% Y-o-Y in 3Q15; results were supported by healthy growth in total banking income, contained expenses, yet muted by higher provisions Y-o-Y.

For full report and financial statements, please click on the links on top of the page.

For further information:

Investor Relations Contacts

Email: investor-relations@efg-hermes.com

Head of Investor Relations

Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

Fax: +20(0)2 3535 7017

www.efg-hermes.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTGRBDBRXBBGUB
Date   Source Headline
25th Apr 20123:45 pmRNSSecond Price Monitoring Extn
25th Apr 20123:40 pmRNSPrice Monitoring Extension
10th Apr 20127:00 amRNSFY2011 Results
28th Mar 20129:36 amRNSStatement re Damas International Limited
26th Mar 20128:49 amRNSStatement re Strategic Alliance with QInvest
19th Mar 201211:07 amRNSStatement re. Press Comment
14th Feb 20129:33 amRNSStatement re CEO Travel Ban
8th Feb 20128:33 amRNSStatement re CEO Travel Ban
6th Feb 20127:42 amRNSStatement re - CEO Travel Ban
17th Jan 20123:45 pmRNSSecond Price Monitoring Extn
17th Jan 20123:40 pmRNSPrice Monitoring Extension
16th Nov 20119:28 amRNS3rd Quarter Results
10th Oct 20113:45 pmRNSSecond Price Monitoring Extn
10th Oct 20113:40 pmRNSPrice Monitoring Extension
4th Oct 20119:53 amRNSStatement re. Press Comment
19th Sep 20113:45 pmRNSSecond Price Monitoring Extn
19th Sep 20113:40 pmRNSPrice Monitoring Extension
19th Sep 20112:00 pmRNSStatement re Bonus Shares Distribution
2nd Sep 20113:40 pmRNSPrice Monitoring Extension
15th Aug 20117:00 amRNS2nd Quarter results
11th Aug 20113:45 pmRNSSecond Price Monitoring Extn
11th Aug 20113:40 pmRNSPrice Monitoring Extension
1st Aug 20113:45 pmRNSSecond Price Monitoring Extn
1st Aug 20113:40 pmRNSPrice Monitoring Extension
19th Jul 20113:45 pmRNSSecond Price Monitoring Extn
19th Jul 20113:40 pmRNSPrice Monitoring Extension
13th Jul 20113:45 pmRNSSecond Price Monitoring Extn
13th Jul 20113:40 pmRNSPrice Monitoring Extension
6th Jul 201111:53 amRNSRegulatory Approval
27th Jun 20113:45 pmRNSSecond Price Monitoring Extn
27th Jun 20113:40 pmRNSPrice Monitoring Extension
15th Jun 20119:28 amRNS1st Quarter Results
13th Jun 201110:36 amRNSEGM & AGM Statement
6th Jun 20117:00 amRNSTreasury Stock
25th May 20119:29 amRNSNotice of AGM & EGM
10th May 20113:40 pmRNSPrice Monitoring Extension
5th May 20113:45 pmRNSSecond Price Monitoring Extn
5th May 20113:40 pmRNSPrice Monitoring Extension
4th May 20113:40 pmRNSPrice Monitoring Extension
28th Apr 20113:40 pmRNSPrice Monitoring Extension
27th Apr 20111:12 pmRNSStatement re Board of Directors
26th Apr 20113:40 pmRNSPrice Monitoring Extension
26th Apr 201110:32 amRNSStatement re Board of Directors
18th Apr 20119:51 amRNSDirectorate Change
30th Mar 20112:19 pmRNSStatement re news published on the company
30th Mar 20119:47 amRNSAnnual Financial Report
29th Mar 20115:00 pmRNSDirectorate Change
14th Feb 20117:10 amRNSStatement re clarification of ownership
10th Feb 20113:45 pmRNSSecond Price Monitoring Extn
10th Feb 20113:40 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.